Twist Bioscience Share Price (NASDAQ: TWST)

$28.59

▲

2.12

(8.01%)

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Twist Bioscience Stock chart to analyse performance

Twist Bioscience stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$26.67
Today's High:$28.69
$28.59
6.72%
Downside
Day's Volatility :7.04%
Upside
0.35%
52 Weeks Low:$24.28
52 Weeks High:$55.33
$28.59
15.08%
Downside
52 Weeks Volatility :56.12%
Upside
48.33%

Twist Bioscience Stock Returns

Period	Twist Bioscience Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.86%	6.0%	0.0%
6 Months	-30.66%	-5.6%	0.0%
1 Year	-34.56%	-11.1%	0.0%
3 Years	-34.95%	6.8%	-7.8%

Twist Bioscience Corp Key Stats

Check Twist Bioscience key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$26.47
Open	$26.71
Today's High	$28.69
Today's Low	$26.67
Market Capitalization	$1.6B
Today's Volume	$1.1M
52 Week High	$55.3325
52 Week Low	$24.28
Revenue TTM	$362.3M
EBITDA	$-119.5M
Earnings Per Share (EPS)	$-1.44
Profit Margin	-23.52%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.58%

Stock Returns calculator for Twist Bioscience Stock including INR - Dollar returns

The Twist Bioscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Twist Bioscience investment value today

Current value as on today

₹69,799

Returns

₹30,201

(-30.2%)

Returns from Twist Bioscience Stock

₹34,517 (-34.52%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Twist Bioscience Stock

-8%

Period: Jul 23, 2025 to Aug 22, 2025. Change in 30 Days versus previous period

Search interest for Twist Bioscience Stock from India on INDmoney has decreased by -8% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Twist Bioscience Corp

Name
Holdings %
Name
Holdings %
ARK Investment Management LLC
10.60%
Vanguard Group Inc
9.66%
BlackRock Inc
9.33%
Artisan Partners Limited Partnership
8.38%
William Blair Investment Management, LLC
6.47%
Amvescap Plc.
5.61%

Analyst Recommendation on Twist Bioscience Stock

Rating

Trend

Buy

81%Buy

12%Hold

6%Sell

Based on 16 Wall street analysts offering stock ratings for Twist Bioscience(by analysts ranked 0 to 5 stars)

Twist Bioscience Share Price Target

What analysts predicted

Upside of 39.91%

Target:

$40.00

Current:

$28.59

Twist Bioscience share price target is $40.00, a slight Upside of 39.91% compared to current price of $28.59 as per analysts' prediction.

Twist Bioscience Stock Insights

Price Movement
In the last 1 month, TWST stock has moved down by -20.7%
Increasing Revenue
Revenue is up for the last 11 quarters, 54.24M → 96.05M (in $), with an average increase of 5.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -39.32M → 20.39M (in $), with an average increase of 292.9% per quarter
TWST vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 32.2% return, outperforming this stock by 66.8%
TWST vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 80.8% return, outperforming this stock by 112.3%
Price to Sales
ForTWST every $1 of sales, investors are willing to pay $4.7, whereas for Idexx Laboratories, Inc., the investors are paying $13.0 for every $1 of sales.

Twist Bioscience Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$54.4M	↑ 113.89%
Net Income	$-107.7M	↑ 51.14%
Net Profit Margin	-197.98%	↑ 82.18%

	FY20	Y/Y Change
Revenue	$90.1M	↑ 65.67%
Net Income	$-139.9M	↑ 29.96%
Net Profit Margin	-155.31%	↑ 42.67%

	FY21	Y/Y Change
Revenue	$132.3M	↑ 46.87%
Net Income	$-152.1M	↑ 8.69%
Net Profit Margin	-114.94%	↑ 40.37%

	FY22	Y/Y Change
Revenue	$203.6M	↑ 53.83%
Net Income	$-217.9M	↑ 43.24%
Net Profit Margin	-107.02%	↑ 7.92%

	FY23	Y/Y Change
Revenue	$245.1M	↑ 20.41%
Net Income	$-204.6M	↓ 6.08%
Net Profit Margin	-83.48%	↑ 23.54%

	FY24	Y/Y Change
Revenue	$313.0M	↑ 27.69%
Net Income	$-208.7M	↑ 2.01%
Net Profit Margin	-66.69%	↑ 16.79%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$75.3M	↑ 5.32%
Net Income	$-45.5M	↑ 5.78%
Net Profit Margin	-60.41%	↓ 0.26%

	Q2 FY24	Q/Q Change
Revenue	$81.5M	↑ 8.18%
Net Income	$-85.6M	↑ 88.1%
Net Profit Margin	-105.04%	↓ 44.63%

	Q3 FY24	Q/Q Change
Revenue	$84.7M	↑ 3.98%
Net Income	$-34.7M	↓ 59.5%
Net Profit Margin	-40.91%	↑ 64.13%

	Q4 FY24	Q/Q Change
Revenue	$88.7M	↑ 4.73%
Net Income	$-31.6M	↓ 8.83%
Net Profit Margin	-35.61%	↑ 5.3%

	Q1 FY25	Q/Q Change
Revenue	$92.8M	↑ 4.6%
Net Income	$-39.3M	↑ 24.48%
Net Profit Margin	-42.38%	↓ 6.77%

	Q2 FY25	Q/Q Change
Revenue	$96.1M	↑ 3.52%
Net Income	$20.4M	↓ 151.85%
Net Profit Margin	21.23%	↑ 63.61%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$7.0M	↓ 202.91%

	FY20	Y/Y Change
Profit	$28.7M	↑ 312.33%

	FY21	Y/Y Change
Profit	$51.7M	↑ 80.22%

	FY22	Y/Y Change
Profit	$84.2M	↑ 62.89%

	FY23	Y/Y Change
Profit	$89.7M	↑ 6.52%

	FY24	Y/Y Change
Profit	$133.3M	↑ 48.61%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$30.9M	↑ 6.63%

	Q2 FY24	Q/Q Change
Profit	$35.3M	↑ 14.21%

	Q3 FY24	Q/Q Change
Profit	$38.2M	↑ 8.4%

	Q4 FY24	Q/Q Change
Profit	$42.8M	↑ 12.05%

	Q1 FY25	Q/Q Change
Profit	$46.0M	↑ 7.44%

	Q2 FY25	Q/Q Change
Profit	$51.3M	↑ 11.45%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-87.9M	↑ 32.91%
Investing Cash Flow	$-104.8M	↓ 490.03%
Financing Cash Flow	$158.6M	↑ 78.53%

	FY20	Y/Y Change
Operating Cash Flow	$-142.3M	↑ 61.77%
Investing Cash Flow	$-114.7M	↑ 9.39%
Financing Cash Flow	$303.7M	↑ 91.53%

	FY21	Y/Y Change
Operating Cash Flow	$-112.2M	↓ 21.1%
Investing Cash Flow	$156.2M	↓ 236.2%
Financing Cash Flow	$329.2M	↑ 8.38%

	FY22	Y/Y Change
Operating Cash Flow	$-124.4M	↑ 10.82%
Investing Cash Flow	$-232.9M	↓ 249.17%
Financing Cash Flow	$270.5M	↓ 17.82%

	FY23	Y/Y Change
Operating Cash Flow	$-142.5M	↑ 14.54%
Investing Cash Flow	$50.6M	↓ 121.73%
Financing Cash Flow	$911.0K	↓ 99.66%

	FY24	Y/Y Change
Operating Cash Flow	$-64.1M	↓ 55.01%
Investing Cash Flow	$-3.1M	↓ 106.07%
Financing Cash Flow	$6.9M	↑ 656.31%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-19.4M	↓ 15.45%
Investing Cash Flow	$-5.2M	↓ 225.81%
Financing Cash Flow	$1.8M	↓ 224.1%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-6.4M	↓ 67.16%
Investing Cash Flow	$-711.0K	↓ 86.43%
Financing Cash Flow	$2.9M	↑ 59.08%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-15.3M	↑ 140.2%
Investing Cash Flow	$-1.3M	↑ 80.73%
Financing Cash Flow	$3.6M	↑ 24.72%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-21.4M	↑ 39.87%
Investing Cash Flow	$-1.5M	↑ 19.53%
Financing Cash Flow	$17.9M	↑ 394.73%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-13.0M	↓ 39.4%
Investing Cash Flow	$-1.4M	↓ 7.16%
Financing Cash Flow	$3.2M	↓ 82.19%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-1.4M	↓ 89.22%
Investing Cash Flow	$-9.4M	↑ 558.98%
Financing Cash Flow	$1.8M	↓ 42.87%

Twist Bioscience Technicals Summary

Sell

Neutral

Buy

Twist Bioscience is currently in a neutral trading position according to technical analysis indicators.

Twist Bioscience Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Twist Bioscience Corp	-18.56%	-30.66%	-34.56%	-34.95%	-56.9%
Agilent Technologies Inc.	1.06%	-10.09%	-13.66%	-9.01%	24.62%
Idexx Laboratories, Inc.	17.35%	39.2%	32.22%	79.0%	69.57%
Thermo Fisher Scientific, Inc.	5.3%	-6.6%	-17.48%	-12.73%	19.16%
Danaher Corp.	4.37%	0.25%	-21.45%	-25.71%	2.97%
Iqvia Holdings Inc.	-4.84%	-1.87%	-23.23%	-17.56%	22.32%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Twist Bioscience Corp	NA	NA	NA	-2.32	-0.18	-0.14	NA	7.95
Agilent Technologies Inc.	28.85	28.85	1.75	5.58	0.19	0.08	0.01	21.61
Idexx Laboratories, Inc.	52.62	52.62	4.79	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.01	28.01	2.02	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.29	43.29	2.12	7.77	0.07	0.04	0.01	73.1
Iqvia Holdings Inc.	26.91	26.91	1.1	11.87	0.2	0.05	NA	33.99

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Twist Bioscience Corp	Buy	$1.6B	-56.9%	NA	-23.52%
Agilent Technologies Inc.	Buy	$33.3B	24.62%	28.85	17.59%
Idexx Laboratories, Inc.	Buy	$50.6B	69.57%	52.62	24.41%
Thermo Fisher Scientific, Inc.	Buy	$182.7B	19.16%	28.01	15.24%
Danaher Corp.	Buy	$146.0B	2.97%	43.29	14.21%
Iqvia Holdings Inc.	Buy	$31.5B	22.32%	26.91	7.88%

Twist Bioscience Dividend announcements

Twist Bioscience Earnings
Twist Bioscience’s price-to-earnings ratio stands at None

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Organization	Twist Bioscience
Employees	923
CEO	Dr. Emily Marine Leproust Ph.D.
Industry	Health Technology

Key Management of Twist Bioscience Corp

Name	Title
Dr. Emily Marine Leproust Ph.D.	Co-Founder, Board Chair & CEO
Dr. Patrick John Finn Ph.D.	President & COO
Mr. Adam Laponis	Chief Financial Officer
Mr. Dennis Cho J.D.	Senior VP, Chief Legal Officer & Corporate Secretary
Ms. Paula Green	Senior Vice President of Human Resources
Mr. Robert F. Werner	VP & Chief Accounting Officer
Mr. Siyuan Chen	Chief Technology Officer
Dr. Michael Fero Ph.D.	Chief Information Officer
Ms. Nicole Moreno	Senior Vice President of Sales & Support
Ms. Angela Bitting	Chief Corporate Responsibility Officer & Senior VP of Corporate Affairs

Important FAQs about investing in TWST Stock from India :

What is Twist Bioscience share price today?

Twist Bioscience share price today is $28.59 as on August 23, 2025 at 1:29 AM IST at the close of the market. Twist Bioscience share today touched a day high of $28.69 and a low of $26.67.

What is the 52 week high and 52 week low for Twist Bioscience share?

Twist Bioscience share touched a 52 week high of $55.33 and a 52 week low of $24.28. Twist Bioscience stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $28.59, lower by 48.33% versus the 52 week high.

How to invest in Twist Bioscience Stock (TWST) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Twist Bioscience on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Twist Bioscience Shares that will get you 0.0525 shares as per Twist Bioscience share price of $28.59 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Twist Bioscience Stock (TWST) from India?

Indian investors can start investing in Twist Bioscience (TWST) shares with as little as ₹87.521 or $1 (as of August 23, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Twist Bioscience stock (as per the Rupee-Dollar exchange rate as on August 23, 2025). Based on Twist Bioscience share’s latest price of $28.59 as on August 23, 2025 at 1:29 AM IST, you will get 0.3498 shares of Twist Bioscience. Learn more about fractional shares .

What are the returns that Twist Bioscience has given to Indian investors in the last 5 years?

Twist Bioscience stock has given -56.9% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?